Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.95703 | 83 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.85779 | 81 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.31717 | 85 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.04463 | 82 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.93014 | 82 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 6.07012 | 84 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.68089 | 81 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 6.00824 | 83 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.37501 | 85 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.17282 | 83 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.97466 | 82 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.94064 | 82 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.61271 | 80 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.03668 | 83 |